{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:24:00Z","timestamp":1792160640696,"version":"4.4.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011751","name":"Stiftelsen f\u00f6r Strategisk Forskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017018","name":"Wallenberg Centre for Molecular and Translational Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>\n                    Cellular senescence is a state of irreversible cell cycle arrest and has been shown to play a key role in many diseases, including metabolic diseases. To investigate the potential contribution of hepatocyte cellular senescence to the metabolic derangements associated with non-alcoholic steatohepatitis (NASH), we treated human hepatocyte cell lines HepG2 and IHH with the senescence-inducing drugs nutlin-3a, doxorubicin and etoposide. The senescence-associated markers p16, p21, p53 and beta galactosidase were induced upon drug treatment, and this was associated with increased lipid storage, increased expression of lipid transporters and the development of hepatic steatosis. Drug-induced senescence also led to increased glycogen content, and increased VLDL secretion from hepatocytes. Senescence was also associated with an increase in glucose and fatty acid oxidation capacity, while\n                    <jats:italic>de novo<\/jats:italic>\n                    lipogenesis was decreased. Surprisingly, cellular senescence caused an overall increase in insulin signaling in hepatocytes, with increased insulin-stimulated phosphorylation of IR, Akt, and MAPK. Together, these data indicate that hepatic senescence plays a causal role in the development of NASH pathogenesis, by modulating glucose and lipid metabolism, favoring steatosis. Our findings contribute to a better understanding of the mechanisms linking cellular senescence and fatty liver disease and support the development of new therapies targeting senescent cells for the treatment of NASH.\n                  <\/jats:p>","DOI":"10.3389\/fendo.2022.957616","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T01:20:05Z","timestamp":1661131205000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":46,"title":["Cellular senescence in hepatocytes contributes to metabolic disturbances in NASH"],"prefix":"10.3389","volume":"13","author":[{"given":"Laurianne","family":"Bonnet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Alexandersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritesh K.","family":"Baboota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Kroon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Oscarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremie","family":"Boucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(22)00003-1","article-title":"A global view of the interplay between non-alcoholic fatty liver disease and diabetes","volume":"10","author":"Stefan","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hep.28839","article-title":"Nonalcoholic steatohepatitis in nonobese patients: Not so different after all","volume":"65","author":"Cusi","year":"2017","journal-title":"Hepatology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40842-020-00097-1","article-title":"Nonalcoholic fatty liver disease and type 2 diabetes: where do diabetologists stand","volume":"6","author":"Tomah","year":"2020","journal-title":"Clin Diabetes Endocrinol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"100089","DOI":"10.1016\/j.endmts.2021.100089","article-title":"The global epidemiology of nonalcoholic steatohepatitis (NASH) and associated risk factors\u2013a targeted literature review","volume":"3","author":"Dufour","year":"2021","journal-title":"Endocrine Metab Sci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/0014-4827(61)90192-6","article-title":"The serial cultivation of human diploid cell strains","volume":"25","author":"Hayflick","year":"1961","journal-title":"Exp Cell Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4827(65)90211-9","article-title":"The limited in vitro lifetime of human diploid cell strains","volume":"37","author":"Hayflick","year":"1965","journal-title":"Exp Cell Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i34.5069","article-title":"Hepatic senescence, the good and the bad","volume":"25","author":"Huda","year":"2019","journal-title":"World J Gastroenterol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2233","article-title":"Cellular senescence: when bad things happen to good cells","volume":"8","author":"Campisi","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.10.031","article-title":"Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease","volume":"58","author":"Aravinthan","year":"2013","journal-title":"J Hepatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"100301","DOI":"10.1016\/j.jhepr.2021.100301","article-title":"Evaluating causality of cellular senescence in non-alcoholic fatty liver disease","volume":"3","author":"Meijnikman","year":"2021","journal-title":"JHEP Rep Innovation Hepatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"15691","DOI":"10.1038\/ncomms15691","article-title":"Cellular senescence drives age-dependent hepatic steatosis","volume":"8","author":"Ogrodnik","year":"2017","journal-title":"Nat Commun"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00032.2011","article-title":"Hepatic cellular senescence pathway genes are induced through histone modifications in a diet-induced obese rat model","volume":"302","author":"Zhang","year":"2012","journal-title":"Am J Physiol Gastrointestinal liver Physiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i47.17851","article-title":"Senescent human hepatocytes express a unique secretory phenotype and promote macrophage migration","volume":"20","author":"Irvine","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00365.2018","article-title":"Lipid and glucose metabolism in hepatocyte cell lines and primary mouse hepatocytes: a comprehensive resource for in vitro studies of hepatic metabolism","volume":"316","author":"Nagarajan","year":"2019","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J Biol Chem"},{"key":"B17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/B978-0-12-416618-9.00020-0","article-title":"Measurement of fatty acid oxidation rates in animal tissues and cell lines","volume":"542","author":"Huynh","year":"2014","journal-title":"Methods Enzymology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1126\/science.1092472","article-title":"In vivo activation of the p53 pathway by small-molecule antagonists of MDM2","volume":"303","author":"Vassilev","year":"2004","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","first-page":"31758","DOI":"10.1038\/srep31758","article-title":"Identification of cellular senescence-specific genes by comparative transcriptomics","volume":"6","author":"Nagano","year":"2016","journal-title":"Sci Rep"},{"key":"B20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jcmgh.2019.03.001","article-title":"Senescent hepatocytes in decompensated liver show reduced UPR(MT) and its key player, CLPP, attenuates senescence in vitro","volume":"8","author":"Sen","year":"2019","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2018.02.001","article-title":"Hallmarks of cellular senescence","volume":"28","author":"Hernandez-Segura","year":"2018","journal-title":"Trends Cell Biol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2019.07.021","article-title":"Hallmarks of aging in the liver","volume":"17","author":"Hunt","year":"2019","journal-title":"Comput Struct Biotechnol J"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-019-4934-x","article-title":"Cellular senescence: at the nexus between ageing and diabetes","volume":"62","author":"Palmer","year":"2019","journal-title":"Diabetologia"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2013.08.039","article-title":"Analysis of in vitro insulin-resistance models and their physiological relevance to in vivo diet-induced adipose insulin resistance","volume":"5","author":"Lo Kinyui","year":"2013","journal-title":"Cell Rep"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2174\/138161211795222603","article-title":"Pharmacologic activation of p53 by small-molecule MDM2 antagonists","author":"Shen","year":"2011","journal-title":"Curr Pharm Design"},{"key":"B26","doi-asserted-by":"publisher","first-page":"101558","DOI":"10.1016\/j.molmet.2022.101558","article-title":"Chronic hyperinsulinemia promotes human hepatocyte senescence","volume":"19","author":"Baboota","year":"2022","journal-title":"Mol Metab"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s10522-018-9763-7","article-title":"Obesity and type-2 diabetes as inducers of premature cellular senescence and ageing","volume":"19","author":"Burton","year":"2018","journal-title":"Biogerontology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.4103\/ijem.IJEM_585_17","article-title":"Nonalcoholic fatty liver disease and type 2 diabetes mellitus","volume":"22","author":"Dharmalingam","year":"2018","journal-title":"Indian J Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","first-page":"6613827","DOI":"10.1038\/s41575-021-00448-y","article-title":"And diabetes mellitus type 2","volume":"2021","author":"Maru\u0161i\u0107","year":"2021","journal-title":"Can J Gastroenterol Hepatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments","volume":"18","author":"Targher","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-0329","article-title":"Role of patatin-like phospholipase domain-containing 3 gene for hepatic lipid content and insulin resistance in diabetes","volume":"43","author":"Zaharia","year":"2020","journal-title":"Diabetes Care"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.arr.2017.10.003","article-title":"Inflammageing and metaflammation: The yin and yang of type 2 diabetes","volume":"41","author":"Prattichizzo","year":"2018","journal-title":"Ageing Res Rev"},{"key":"B33","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/labinvest.3700590","article-title":"Microarray analyses and molecular profiling of steatosis induction in immortalized human hepatocytes","volume":"87","author":"De Gottardi","year":"2007","journal-title":"Lab Investigation; J Tech Methods Pathol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1152\/physiol.00048.2018","article-title":"Hepatic insulin clearance: Mechanism and physiology","volume":"34","author":"Najjar","year":"2019","journal-title":"Physiol (Bethesda Md)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01501-8","article-title":"Obesity and hyperinsulinemia drive adipocytes to activate a cell cycle program and senesce","volume":"27","author":"Li","year":"2021","journal-title":"Nat Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020652","article-title":"The potential role of cellular senescence in non-alcoholic fatty liver disease","volume":"23","author":"Engelmann","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00074.2008","article-title":"Gene expression in human NAFLD","volume":"294","author":"Greco","year":"2008","journal-title":"Am J Physiol Gastrointestinal Liver Physiol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.222844","article-title":"Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis c","volume":"60","author":"Miquilena-Colina","year":"2011","journal-title":"Gut"},{"key":"B39","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1053\/j.gastro.2010.05.039","article-title":"Fatty acid metabolism in the liver, measured by positron emission tomography, is increased in obese individuals","volume":"139","author":"Iozzo","year":"2010","journal-title":"Gastroenterology"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.710420","article-title":"Metabolic changes of hepatocytes in NAFLD","volume":"12","author":"Lu","year":"2021","journal-title":"Front Physiol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07725.x","article-title":"Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test","volume":"98","author":"Miele","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.11.038","article-title":"Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease","volume":"134","author":"Fabbrini","year":"2008","journal-title":"Gastroenterology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nrd.2016.151","article-title":"Targeting hepatic glucose metabolism in the treatment of type 2 diabetes","volume":"15","author":"Rines","year":"2016","journal-title":"Nat Rev Drug Discov"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.957616\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T01:20:09Z","timestamp":1661131209000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.957616\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,22]]},"references-count":43,"alternative-id":["10.3389\/fendo.2022.957616"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.957616","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,22]]},"article-number":"957616"}}